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EXPERT’S CORNER: A  PERSONAL APPROACH
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The  normal  iron  content  of  the body  is  3--4  g.  It  exists
in  hemoglobin,  in iron-containing  proteins  different  to
hemoglobin,  in  iron  bound  to  transferrin  in plasma,  and  in
the  form  of ferritin  and  hemosiderin.  There is  approximately
1  g  of  storage  iron,  mostly  in liver,  spleen,  and  bone  marrow.1
Iron  is lost in sweat,  shed  skin  cells,  and  gastrointesti-
nal  loss  at  a  rate  of  approximately  1 mg/day.  Menstruating
women  lose  an  additional  0.5  mg/day  to 1.0  mg/day  of  iron.
Iron  overload  occurs  when  there  is  increased  absorption
of  iron  from  a  normal  diet,  or  when the subject  has  received
large  doses  of  parenteral  iron  from  multiple  red  cell trans-
fusions  or  multiple  infusions  of intravenous  iron.
Etiology
There  is  no  mechanism  for  iron  excretion  once  it has been
absorbed  into  the body  therefore  iron  overload  is  found in
the  following  conditions.2--4
Increased  absorption  from  a normal  diet
Seen  in  the  various  forms  of hereditary  hemochromatosis,
in  patients  with  thalassemia  with  ineffective  erythropoiesis,
and  in  patients  with  congenital  or  acquired  clonal  siderob-
lastic  anemia.  In all  of  these  conditions,  there  is  relative
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or  absolute  deficiency  of  the  iron-regulatory  hormone  hep-
cidin.
Hereditary  hemochromatosis
In patients  with  homozygous  hereditary  hemochromatosis
(HH),  the  absorption  of  iron  is  not regulated  by  serum
ferritin.5 These  patients  may  absorb  2--4  mg  of  iron.3
Multiple  infusions  of iron-containing  agents
Iron  overload  can  occur  secondary  to multiple  intravenous
infusions  of  the following  iron-containing  products:
• Red  cell  transfusions.  Each  red  blood  cells  unit  contains
200 mg of  elemental  iron.  Patients  who  have  received
more  than  10  red  cell transfusions  are at risk  of  iron  over-
load.
•  Intravenous  iron.  Patients  with  renal  failure  and  cancer
patients  who  have  been  treated  with  multiple  courses  of
intravenous  iron  in  addition  to  erythropoiesis-stimulating
agents  may  develop  iron overload.
•  Intravenous  hemin/hematin.  Patients  with  porphyria  are
at  risk  of  developing  iron  overload  because  of treatment
with  intravenous  hematin/hemin.
Liver  disease
Acute  and  chronic  liver  disorders  are associated  with  inflam-
mation  and an  increase  in ferritin  levels,  since  ferritin  is  an
acute  phase  reactant.
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• In  alcoholic  liver  disease,  increased  levels  of  iron  can  be
found,  although  not  to  the extent  seen  in patients  with
hereditary  hemochromatosis.
•  In  patients  with  porphyria  cutanea  tarda  and HCV  infec-
tion,  iron  plays  a  role  in the development  of  symptoms.
•  It may  not be  possible  distinguish  some  liver  diseases  from
the  liver  damage  seen  in hereditary  hemochromatosis.
Work  up
Iron  overload  is  demonstrated  by  serum  ferritin,  transferrin
saturation,  Magnetic  Resonance  Image  techniques  (MRI)  and
liver  biopsy.6 All patients  suspected  of  having  iron  overload,
should  also  be  studied  for  HH.
Iron  overload  is  defined  by the  finding  of an increased
transferrin  saturation  with  an increased  plasma  ferritin
concentration  when  the patient  is  free  of  inflammation.
Iron  overload  is  present  when  transferrin  saturation  exceeds
45  percent  and  is  associated  with  tissue  damage  when  it
exceeds  70--75  percent.
The  finding  of  a serum  ferritin  level greater  than
200--300  ng/mL  in men  or  150--200  ng/mL  in women  is  sug-
gestive  of  iron  overload.  Ferritin  is  an  acute  phase  reactant
and  serum  levels  may  fluctuate  over  time,  a  normal  level  of
C-reactive  protein  suggests  that  an elevated  ferritin  is  not
due  to  inflammation  or  infection.  It is  a  poor predictor  of
Liver  Iron  Concentration  (LIC)  for the  individual  patient,  and
its  accuracy  depends  on  the  underlying  liver  disease.7--11 A
high  ferritin  level alone  is  not  sufficient  for  making  the  diag-
nosis  of iron  overload.  It  is  recommended  that  both  serum
ferritin  and  transferrin  saturation  must  be  studied  in all
patients.12
Noninvasive  imaging  studies,  such as CT scanning  and
T2  and  R2  (FerriScan)  measurements  by  MRI,  have  become
increasingly  accurate  for  determining  hepatic  and  cardiac
iron  deposition.6,13--22 A liver  iron  concentration  (LIC)  esti-
mated  by  MRI  greater  than  7 mg Fe/g  dry  weight  indicates
the  presence  of  hepatic  iron  overload  and  a  cardiac  T2  by  MRI
greater  than  20  milliseconds  indicates  cardiac  iron  overload.
Parenchymal  iron  loading  can  be  demonstrated  semi-
quantitatively  by  Perls’  Prussian  blue  staining  of  a liver
biopsy  specimen23,24 and  can  be  directly  analyzed  for  hepatic
iron  content  (HIC).  The  upper  limit  of normal  is 1.4  mg/g  to
1.8  mg/g  and  with  any  value  greater  than  2.0  mg/g  being
considered  abnormal.25,26
When to suspect iron  overload
Iron  overload  is  suspected  in  relatives  of  individuals  with
hereditary  hemochromatosis,  in those  who  have  received
multiple  red  cell transfusions  and  those  with  a  known  disor-
der  or  clinical  situation  predisposing  to  iron  overload.
Since  iron  overload  from any  cause  can  ultimately  lead
to  organ  failure  in the  heart,  liver,  and various  endocrine
organs,  presence  of  one  or  more  of the following  signs  and
symptoms  should  also  make the  clinician  suspect  the pres-
ence  of  iron  overload  with  resulting  organ damage,
•  Unexplained  abnormalities  in liver  function,  chronic  liver
disease,  cirrhosis
•  Cardiac  enlargement  with  or  without  heart  failure  or
conduction  defects
• Diabetes  mellitus
•  Hypogonadism
•  Skin  hyperpigmentation
• Unexplained  fatigue
Diagnosis
Iron  overload  is  diagnosed  by  demonstrating  an elevated
serum/plasma  ferritin  along  with  an  increased  transferrin
saturation  on  more  than  one  occasion,
•  Serum  ferritin  greater  than 200--300  ng/mL  in men  or
150--200  ng/mL  in women
•  Transferrin  saturation  greater  than  45  percent,  and
•  The  following  specialized  tests  document  the  presence
and  magnitude  of  iron  overload
◦  A liver  iron concentration  (LIC)  estimated  by  MRI
greater  than  7 mg  Fe/g  dry  and a cardiac  T2*  by  MRI
greater  than  20  ms.
◦  Levels  of  hepatic  iron  greater  than  2  mg/g  as
obtained  by  liver  biopsy  are indicative  of  hepatic  iron
overload.4,27
•  All  patients  evaluated  for  iron  overload  should  have  C282Y
and  H63D  mutation  analysis  for  diagnosing  the presence
(or  absence)  of  HH.
•  The  finding  of  a  C282Y/C282Y  genotype  confirms  the diag-
nosis  of HH.
•  Heterozygote  genotype  (C282Y/H63D  genotype)  have  a 60
percent  of  an intermediate  degree  of iron  loading.
•  Patients  with  a C282Y/wild  type  (wt)  genotype  are  less
risk  of  iron  overload.28
Summary  and recommendations
Iron  overload  is  seen  in a  number  of  clinical  settings;  most
common  are multiple  transfusions,  liver  disease,  and  hered-
itary  hemochromatosis  (HH).
One  or  more  of  the following  signs  and  symptoms  should
make  the clinician  suspect  the presence  of organ  damage
secondary  to  iron overload
• Unexplained  abnormalities  in liver  function,  chronic  liver
disease  or  cirrhosis
•  Cardiac  enlargement  with  or  without  heart  failure  or
conduction  defects
• Diabetes  mellitus
•  Hypogonadism
•  Skin  hyperpigmentation
• Unexplained  fatigue
•  Positive  family  history  of iron  overload
•  All  patients  suspected  of  having  iron  overload  should  have
iron  studies  as  well  as  genetic  testing.
•  Serum  ferritin  greater  than 200--300  ng/mL  in men  or
150--200  ng/mL  in  women  and/or  a  transferrin  saturation
greater  than  45  percent  indicates  iron overload.
•  A  choice  among these options:
◦  A liver  iron  concentration  estimated  by MRI  greater
than  7 mg Fe/g  dry  weight  indicates  the presence  of
Documento descargado de http://www.elsevier.es el 24-08-2016
242  L.J.  Marfil-Rivera
hepatic  iron  overload  and a cardiac  T2*  over  20  milli-
seconds  indicates  the  presence  of cardiac  iron  overload
◦  A  liver  biopsy  performed  specifically  for the  determi-
nation  of iron  overload  is  rarely  needed.
•  All  patients  being evaluated  for  iron  overload  should  have
C282Y  and  H63D  mutation  analysis.
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